Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, a new trial has found. In women with dense breasts (breasts...
Merck’s immunotherapy drug Keytruda (pembrolizumab) has shown a “statistically significant” survival benefit in platinum-resistant ovarian cancer, potentially offering a new treatment path for patients with few...
British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare...
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated...
Three women’s cancer innovators have been shortlisted for a Femtech World award. The event celebrates some of the best examples of leadership, innovation and impact in...
US regulators have approved the first at-home vaginal self-collection device for cervical cancer screening, offering women an alternative to in-clinic exams. The Teal Wand, developed by women’s...
The most effective way to harness the power of AI when screening for breast cancer may be through collaboration with human radiologists — not by wholesale...
An international group of ovarian cancer research charities has launched a new AI-focused grant aimed at accelerating progress in one of the most underfunded and least...
Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new...
A new study suggests that AI could help detect interval breast cancer — those that develop between routine screenings — before they become more advanced and...
